Vol 7: miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer.Report as inadecuate



 Vol 7: miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer.


Vol 7: miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 7: miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer.
This article is from OncoTargets and therapy, volume 7.AbstractIn the last decade, cancer research efforts in the field of noncoding microRNA miRNA have been growing exponentially. miRNA-based therapeutics have been tested in both preclinical and clinical settings, and miRNA-based cancer diagnostics and prognostics have moved into clinics to help better manage cancer treatment. A growing body of evidence in recent literature suggests miRNA-129 plays important roles in gastrointestinal cancer, including gastric, colorectal, hepatocellular carcinoma, and esophageal cancer. In this review, we focus on accumulating evidence demonstrating the key roles that miRNA-129 plays in tumorigenesis, disease progression, chemoresistance, proliferation, and cell cycle control. Understanding the emerging roles and mechanisms of miRNA-129 in cancer will help us realize the therapeutic and diagnostic-prognostic potential.



Author: Fesler, Andrew; Zhai, Haiyan; Ju, Jingfang

Source: https://archive.org/







Related documents